GRI Bio, Inc. (GRI)
0.2057
+0.01
(+4.84%)
USD |
NASDAQ |
Jan 23, 16:00
0.21
0.00 (0.00%)
After-Hours: 20:00
GRI Bio Total Assets (Quarterly): 4.782M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Ekso Bionics Holdings, Inc. | 21.66M |
| Autonomix Medical, Inc. | 7.932M |
| CEL-SCI Corp. | 28.16M |
| AIM ImmunoTech, Inc. | 5.494M |
| IGC Pharma, Inc. | 9.743M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.789M |
| Shareholders Equity (Quarterly) | 1.993M |
| Debt to Equity Ratio | 0.0421 |
| Current Ratio | 1.702 |
| Net Debt Paydown Yield | 0.17% |